Literature DB >> 18222009

Involvement of a Leishmania thymidine kinase in flagellum formation, promastigote shape and growth as well as virulence.

Meike Thiel1, Simone Harder, Martin Wiese, Manfred Kroemer, Iris Bruchhaus.   

Abstract

Leishmania promastigote cells transmitted by their insect vector get phagocytosed by macrophages and convert into the amastigote form. In a recently performed proteomic study, a thymidine kinase (TK) was found to be preferentially expressed in amastigotes. Western blot analysis showing a marked increase in TK protein synthesis during stage differentiation from promastigotes to amastigotes confirmed this result. After comparison of the amino acid sequence of Leishmania donovani and Leishmania major thymidine kinases with thymidine kinases of other organisms the Leishmania protein has to be classified as a type II TK. Therefore, in accordance with the nomenclature of other thymidine kinases we named the Leishmania enzymes LdTK1 and LmTK1, respectively. The LdTK1 is localised within the cytoplasm of promastigotes. In amastigotes, increased expression and a clustered distribution of the protein can be observed. Lmtk1 single allele gene replacement mutants have significantly elongated flagellum. In contrast, lmtk1 double allele gene replacement mutants show a remarkably reduced flagellar length, diminished overall size and a deformed body shape. In addition, they have a 12-fold reduced growth rate. For both mutant strains, macrophage infectivity is clearly reduced compared to a L. major wildtype infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18222009     DOI: 10.1016/j.molbiopara.2007.12.005

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  7 in total

Review 1.  Leishmania sand fly interaction: progress and challenges.

Authors:  Paul A Bates
Journal:  Curr Opin Microbiol       Date:  2008-07-25       Impact factor: 7.934

2.  Leishmania adaptor protein-1 subunits are required for normal lysosome traffic, flagellum biogenesis, lipid homeostasis, and adaptation to temperatures encountered in the mammalian host.

Authors:  James E Vince; Dedreia L Tull; Timothy Spurck; Merran C Derby; Geoffrey I McFadden; Paul A Gleeson; Suzanne Gokool; Malcolm J McConville
Journal:  Eukaryot Cell       Date:  2008-05-30

3.  A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient.

Authors:  Rogéria C Zauli; Jenicer Ku Yokoyama-Yasunaka; Danilo C Miguel; Alexandre S Moura; Ledice Ia Pereira; Ildefonso A da Silva; Lucianna Gn Lemes; Miriam L Dorta; Milton Ap de Oliveira; André N Pitaluga; Edna Ay Ishikawa; Juliany Cf Rodrigues; Yara M Traub-Cseko; A Tania Bijovsky; Fátima Ribeiro-Dias; Silvia Rb Uliana
Journal:  Parasit Vectors       Date:  2012-01-11       Impact factor: 3.876

4.  Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major.

Authors:  Jennifer Timm; Cristina Bosch-Navarrete; Eliseo Recio; Joanne E Nettleship; Heather Rada; Dolores González-Pacanowska; Keith S Wilson
Journal:  PLoS Negl Trop Dis       Date:  2015-05-15

5.  Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: Implications for pyrimidine-based chemotherapy.

Authors:  Khalid J H Alzahrani; Juma A M Ali; Anthonius A Eze; Wan Limm Looi; Daniel N A Tagoe; Darren J Creek; Michael P Barrett; Harry P de Koning
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-04-20       Impact factor: 4.077

6.  Pyrimidine Salvage Enzymes Are Essential for De Novo Biosynthesis of Deoxypyrimidine Nucleotides in Trypanosoma brucei.

Authors:  Christopher Leija; Filipa Rijo-Ferreira; Lisa N Kinch; Nick V Grishin; Nicole Nischan; Jennifer J Kohler; Zeping Hu; Margaret A Phillips
Journal:  PLoS Pathog       Date:  2016-11-07       Impact factor: 6.823

Review 7.  Fresh insights into the pyrimidine metabolism in the trypanosomatids.

Authors:  Kartikeya Tiwari; Vikash Kumar Dubey
Journal:  Parasit Vectors       Date:  2018-02-08       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.